Alpha emitter radium-223 in patients with metastatic castration-resistant prostate cancer: A cost-utility analysis

• Main Authors: Xiaohui Zeng (Author), Qiao Liu (Author), Chongqing Tan (Author), Xiaomin Wan (Author), Yunhua Wang (Author), Xiaowei Ma (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Objective: To assess the cost effectiveness of radium-223 dichloride for patients with metastatic castration-resistant prostate cancer (mCRPC) in China.Materials and methods: A Markov model was developed to estimate the long-term health and economic outcomes of radium-223 plus best standard care (BS...